Eptinezumab

ATC N02CD05 · 10 markets · 14 records

Eptinezumab 10 markets · 14 records Forms

AU 3 records · 3 strengths

  • 100 mg/1 mLinjectionVyepti also in GB·FR
  • 100 mg/mLinjectionVYEPTI eptinezumab 100 mg/mL concentrated injection single use vial also in SG unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

CA 2 records · 2 strengths

ES 2 records · 1 strengths

US 1 records · 1 strengths

GB 1 records · 1 strengths

  • 100 mg/1 mLinjectionVyepti 100mg/1ml concentrate for solution for infusion vials also in AU·FR

SG 1 records · 1 strengths

  • 100 mg/mLinjectionVYEPTI CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/ML also in AU

MX 1 records · 1 strengths

    1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

    HK 1 records · 1 strengths

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
      With a brand name Con nombre comercial 有商品名 有商品名VYEPTI CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/1ML ×1

      Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

        FR 1 records · 1 strengths

        • 100 mg/1 mLinjectionVYEPTI 100 mg, solution à diluer pour perfusion also in AU·GB

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.